The global demand for high-purity Mimosa Hostilis Root Extract has seen a 15% CAGR since 2020. While South America remains the primary source for raw bark, the Asia-Pacific region, led by China, has become the global hub for high-tech processing and standardized extract production.
Chinese extraction facilities utilize advanced Supercritical CO2 Extraction and Vacuum Spray Drying technologies. This results in an "Information Gain" for buyers: higher active ingredient retention, lower heavy metal content, and a significantly lower carbon footprint compared to traditional solvent-based methods.
Modern applications extend beyond traditional use. Current clinical studies are exploring the extract's antimicrobial properties and its efficacy in regenerating skin tissue, leading to a surge in demand from the global dermaceutical industry.
Years Industry Experience
Global Long-term Clients
Annual Export Volume
Strategic Supply Partners
For procurement officers and R&D scientists, understanding the chemical profile of Mimosa Hostilis is critical. The extract is typically standardized to a specific tannin percentage (often >30%) to ensure consistency in industrial dye or cosmetic formulation.
In Europe and North America, MHRB is used in "Anti-Pollution" and "Skin Repair" serums. Its natural antioxidant properties provide a protective barrier against oxidative stress.
The rise of sustainable fashion has revitalized the use of Mimosa as a natural dye. It produces deep, color-fast purples and browns without the need for toxic mordants.
We provide pharmaceutical-grade extracts that undergo HPLC (High-Performance Liquid Chromatography) testing to verify purity levels, ensuring they meet global regulatory standards for research.
Jiangxi Serum Pharma Industries Co., Ltd. is a professional supplier of pharmaceutical and nutritional products in China. For nearly 10 years, we have been dedicated to exporting biological products, vaccines, Western medicines, raw materials, intermediates, medical consumables, food additives, and plant extracts. Our 2017 establishment marked a shift towards integrated supply chain management, ensuring that every batch of Mimosa Hostilis Root Extract is traceable and compliant.
The market is shifting toward "Wild Harvested" but sustainably managed bark. Buyers now demand documentation regarding the ecological impact of bark stripping in South American forests. Our supply chain emphasizes reforestation and fair-trade practices.
Standard 10:1 extracts are being replaced by 20:1 and 50:1 ratios. Advanced bio-fermentation and co-crystallization techniques (services we provide) allow for higher bio-availability of the active alkaloids and tannins.
For standard industrial extracts, our lead time is 7-10 working days from our China facility to the port of departure. Customized pre-mix or high-ratio extracts may take 14-21 days.
Every batch undergoes multi-stage testing including HPLC for chemical profile, ICP-MS for heavy metals, and microbiological screening. We provide a full Certificate of Analysis (COA) with every shipment.
Yes, we adhere to GMP, BP, and USP standards where applicable. Our facility is ISO-certified, and we have extensive experience navigating the regulatory requirements of over 50 countries.
Absolutely. We specialize in Pre-Mix, Co-Crystallization, and Bio-Fermentation product services to meet the specific formulation needs of our global partners.
Experience the efficiency of high-scale manufacturing combined with pharmaceutical-grade quality control. Let Serum Pharma support your growth in the nutritional and medicinal markets.
Request a Technical Quote
